Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandrine Imbeaud

Showing results (61-70 of 99) with videos related to

Pageof 10
Sort By:
Oncoimmunology|May 10, 2019
<i>APC</i> germline hepatoblastomas demonstrate cisplatin-induced intratumor tertiary lymphoid structuresGuillaume Morcrette, Theo Z Hirsch, Elise Badour, et al.
Plos One|December 6, 2014
Functional study of the Hap4-like genes suggests that the key regulators of carbon metabolism HAP4 and oxidative stress response YAP1 in yeast diverged from a common ancestorNataliya Petryk, You-Fang Zhou, Kateryna Sybirna, et al.
The American Journal of Surgical Pathology|July 28, 2023
Digital Papillary Adenocarcinoma in Nonacral Skin: Clinicopathologic and Genetic Characterization of 5 CasesThibault Kervarrec, Sandrine Imbeaud, David Veyer, et al.
Nature Medicine|May 24, 2016
A MYC-aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancerDaniel Dauch, Ramona Rudalska, Giacomo Cossa, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 16, 2016
Wild-type AAV Insertions in Hepatocellular Carcinoma Do Not Inform Debate Over Genotoxicity Risk of Vectorized AAVJean-Charles Nault, Iadh Mami, Tiziana La Bella, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2014
Molecular classification of malignant pleural mesothelioma: identification of a poor prognosis subgroup linked to the epithelial-to-mesenchymal transitionAurélien de Reyniès, Marie-Claude Jaurand, Annie Renier, et al.
Hepatology (Baltimore, Md.)|March 26, 2019
A 17-Beta-Hydroxysteroid Dehydrogenase 13 Variant Protects From Hepatocellular Carcinoma Development in Alcoholic Liver DiseaseJie Yang, Eric Trépo, Pierre Nahon, et al.
Gastroenterology|April 10, 2013
A hepatocellular carcinoma 5-gene score associated with survival of patients after liver resectionJean-Charles Nault, Aurélien De Reyniès, Augusto Villanueva, et al.
International Journal of Cancer|October 6, 2018
PNPLA3 and TM6SF2 variants as risk factors of hepatocellular carcinoma across various etiologies and severity of underlying liver diseasesJie Yang, Eric Trépo, Pierre Nahon, et al.
Journal of Hepatology|May 4, 2020
Corrigendum to: "BAP1 mutations define a homogeneous subgroup of hepatocellular carcinoma with fibrolamellar-like features and activated PKA" [J Hepatol (2020) 1-13]Théo Z Hirsch, Ana Negulescu, Barkha Gupta, et al.
Pageof 10

Showing results (61-70 of 99) with videos related to

Sort By:
Pageof 10
Oncoimmunology|May 10, 2019
<i>APC</i> germline hepatoblastomas demonstrate cisplatin-induced intratumor tertiary lymphoid structuresGuillaume Morcrette, Theo Z Hirsch, Elise Badour, et al.
Plos One|December 6, 2014
Functional study of the Hap4-like genes suggests that the key regulators of carbon metabolism HAP4 and oxidative stress response YAP1 in yeast diverged from a common ancestorNataliya Petryk, You-Fang Zhou, Kateryna Sybirna, et al.
The American Journal of Surgical Pathology|July 28, 2023
Digital Papillary Adenocarcinoma in Nonacral Skin: Clinicopathologic and Genetic Characterization of 5 CasesThibault Kervarrec, Sandrine Imbeaud, David Veyer, et al.
Nature Medicine|May 24, 2016
A MYC-aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancerDaniel Dauch, Ramona Rudalska, Giacomo Cossa, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 16, 2016
Wild-type AAV Insertions in Hepatocellular Carcinoma Do Not Inform Debate Over Genotoxicity Risk of Vectorized AAVJean-Charles Nault, Iadh Mami, Tiziana La Bella, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2014
Molecular classification of malignant pleural mesothelioma: identification of a poor prognosis subgroup linked to the epithelial-to-mesenchymal transitionAurélien de Reyniès, Marie-Claude Jaurand, Annie Renier, et al.
Hepatology (Baltimore, Md.)|March 26, 2019
A 17-Beta-Hydroxysteroid Dehydrogenase 13 Variant Protects From Hepatocellular Carcinoma Development in Alcoholic Liver DiseaseJie Yang, Eric Trépo, Pierre Nahon, et al.
Gastroenterology|April 10, 2013
A hepatocellular carcinoma 5-gene score associated with survival of patients after liver resectionJean-Charles Nault, Aurélien De Reyniès, Augusto Villanueva, et al.
International Journal of Cancer|October 6, 2018
PNPLA3 and TM6SF2 variants as risk factors of hepatocellular carcinoma across various etiologies and severity of underlying liver diseasesJie Yang, Eric Trépo, Pierre Nahon, et al.
Journal of Hepatology|May 4, 2020
Corrigendum to: "BAP1 mutations define a homogeneous subgroup of hepatocellular carcinoma with fibrolamellar-like features and activated PKA" [J Hepatol (2020) 1-13]Théo Z Hirsch, Ana Negulescu, Barkha Gupta, et al.
Pageof 10